What are the Lindegaard criteria used with transcranial Doppler to differentiate cerebral vasospasm from hyperemia after subarachnoid hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lindegaard Criteria for Cerebral Vasospasm Detection

The Lindegaard ratio is calculated as the mean flow velocity in the middle cerebral artery (MCA) divided by the mean flow velocity in the ipsilateral extracranial internal carotid artery (ICA), with ratios of 5-6 or greater indicating severe vasospasm requiring treatment after subarachnoid hemorrhage. 1

Definition and Calculation

The Lindegaard ratio (also called Lindegaard Index) is a transcranial Doppler (TCD) parameter specifically designed to differentiate true cerebral vasospasm from hyperemia following aneurysmal subarachnoid hemorrhage (SAH). 2

Key calculation components:

  • Numerator: Mean flow velocity (MFV) in the MCA 2
  • Denominator: Mean flow velocity in the ipsilateral extracranial ICA 1
  • Purpose: Distinguishes vasospasm from global hyperperfusion states 1

Interpretation Thresholds

The American Heart Association/American Stroke Association guidelines provide specific ratio cutoffs for vasospasm severity: 1

  • Lindegaard ratio 3-4: Mild vasospasm 3
  • Lindegaard ratio 4-5: Moderate vasospasm 3
  • Lindegaard ratio 5-6 or greater: Severe vasospasm requiring treatment based on clinical situation 1

These thresholds apply to the supraclinoid internal carotid artery, anterior cerebral artery, middle cerebral artery, and vertebrobasilar system. 1

Clinical Rationale and Limitations

The Lindegaard ratio addresses a critical pitfall: absolute MCA velocity values alone can be misleading during triple-H therapy (hypertension/hypervolemia/hemodilution) because both vasospasm and hyperemia cause elevated velocities. 1

Important caveats:

  • TCD monitoring is operator-dependent and requires institutional quality control and threshold establishment 1
  • The ratio helps follow trends rather than providing single-point diagnostic certainty 1
  • Sensitivity and specificity vary considerably depending on the vessel examined 1
  • The European Society of Intensive Care Medicine considers this an advanced skill beyond basic intensivist competency 2

Alternative and Complementary Parameters

Recent research suggests potential improvements over the traditional Lindegaard ratio:

Peak systolic velocity (PSV) and end diastolic velocity (EDV) ratios (MCA/extracranial ICA) may provide better diagnostic accuracy than mean velocity ratios for symptomatic vasospasm. 4

The hyperemia index (bilateral extracranial ICA MFV divided by initial flow velocity) with a cutoff of <1.2 shows promise for distinguishing vasospasm from hyperemia, particularly when transtemporal windows are inadequate. 5

Arteriovenous index (AVI) comparing MCA to basal vein of Rosenthal velocities demonstrates 87% accuracy with AVI >10 for mean velocities, potentially superior to Lindegaard ratio with lower failure rates. 6

Clinical Application Timeline

Vasospasm monitoring should occur during the high-risk period: 1

  • Onset: 3-5 days post-hemorrhage
  • Peak narrowing: 5-14 days post-hemorrhage
  • Resolution: 2-4 weeks post-hemorrhage

TCD should be performed twice daily during this period for optimal monitoring. 3

Treatment Implications

When Lindegaard ratios reach 5-6 or greater, treatment decisions should be guided by clinical context including neurological examination changes, development of new focal deficits, or unexplained increases in mean arterial pressure. 1

Complementary imaging modalities (diffusion-perfusion MRI, xenon-CT cerebral perfusion studies, or cerebral angiography) should be considered alongside TCD findings for comprehensive vasospasm management. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.